ALIGN TECHNOLOGY, INC. Proceeds from Sale and Maturity of Marketable Securities
ALIGN TECHNOLOGY, INC. (ALGN) reported Proceeds from Sale and Maturity of Marketable Securities of $194.68 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2020-02-28
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2011-03-31 was $3.77M, a 24.48% decline year-over-year.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2010-12-31 was $3.12M, a 60.97% decline year-over-year.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2010-09-30 was $6.49M, a 56.37% decline year-over-year.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2010-06-30 was $5.99M.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for fiscal 2019 was $194.68M, a 1936.37% increase from fiscal 2018.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for fiscal 2018 was $9.56M, a 75.82% decline from fiscal 2017.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for fiscal 2017 was $39.54M, a 81.71% decline from fiscal 2016.
- ALIGN TECHNOLOGY, INC. proceeds from sale and maturity of marketable securities for fiscal 2016 was $216.12M, a 620.13% increase from fiscal 2015.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $194.68M 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $9.56M 10-K · filed 2020-02-28 | |||
| 2017-12-31 | $39.54M 10-K · filed 2020-02-28 | |||
| 2016-12-31 | $216.12M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $30.01M 10-K · filed 2018-02-28 | |||
| 2014-12-31 | $82.99M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $31.74M 10-K · filed 2016-02-25 | |||
| 2012-12-31 | $297.00K 10-K · filed 2015-02-26 | |||
| 2011-12-31 | $1.40M 10-K · filed 2014-02-28 | |||
| 2011-03-31 | $3.77M 10-Q · filed 2011-05-05 | $6.88M derived: sum of 2 quarters · filed 2011-05-05 | $13.38M derived: sum of 3 quarters · filed 2011-05-05 | $19.37M derived: sum of 4 quarters · filed 2011-05-05 |
| 2010-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $9.61M derived: sum of 2 quarters · filed 2011-02-24 | $15.60M derived: sum of 3 quarters · filed 2011-02-24 | $20.59M 10-K · filed 2011-02-24 |
| 2010-09-30 | $6.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $12.49M derived: sum of 2 quarters · filed 2010-11-04 | $17.47M 10-Q · filed 2010-11-04 | $25.46M derived: sum of 4 quarters · filed 2011-05-05 |
| 2010-06-30 | $5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $10.98M 10-Q · filed 2010-08-05 | $18.96M derived: sum of 3 quarters · filed 2011-05-05 | $33.85M derived: sum of 4 quarters · filed 2011-05-05 |
| 2010-03-31 | $4.99M 10-Q · filed 2011-05-05 | $12.97M derived: sum of 2 quarters · filed 2011-05-05 | $27.85M derived: sum of 3 quarters · filed 2011-05-05 | |
| 2009-12-31 | $7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $22.87M derived: sum of 2 quarters · filed 2011-02-24 | $48.89M 10-K · filed 2011-02-24 | |
| 2009-09-30 | $14.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $40.91M 10-Q · filed 2010-11-04 | ||
| 2009-06-30 | $26.03M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $87.93M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |